Mireia Caralt

Summary

Affiliation: Hospital Universitari Vall d'Hebron
Country: Spain

Publications

  1. doi request reprint Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma
    Mireia Caralt
    Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Passeig Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Hepatobiliary Pancreat Sci 18:268-75. 2011
  2. doi request reprint Present and Future of Regenerative Medicine: Liver Transplantation
    M Caralt
    Servei Cirurgia Hepatobiliopancreàtica i Trasplants, Hospital Universitari Vall Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Electronic address
    Transplant Proc 47:2377-9. 2015
  3. doi request reprint Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer
    Mireia Caralt
    Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Paseo Vall d Hebron119 129, Barcelona, 08035, Spain
    Ann Surg Oncol 15:2804-10. 2008
  4. doi request reprint Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis
    Gonzalo Sapisochin
    Department of HBP Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Surg Oncol 20:1194-202. 2013
  5. pmc Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre
    Gonzalo Sapisochin
    Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Hepatol Int 5:707-15. 2011
  6. doi request reprint Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series
    Gonzalo Sapisochin
    HBP Surgery and Transplantation Department, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Passeig de la Vall d Hebron 119 129, 08035 Barcelona, Spain
    World J Surg 34:2146-54. 2010
  7. ncbi request reprint Does Matching Donor-Recipient Age Affect Long-Term Survival in Liver Transplantation?
    Cristina Dopazo
    Department of HPB Surgery and Transplants, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Transplant 21:708-716. 2016
  8. pmc Isolated bilateral Tapia's syndrome after liver transplantation: A case report and review of the literature
    Itxarone Bilbao
    Itxarone Bilbao, Cristina Dopazo, Mireia Caralt, Lluis Castells, Elisabeth Pando, Amaia Gantxegi, Ramón Charco, Department of Digestive Surgery, Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitario Vall d Hebron, CIBERehd, Universidad Autonoma de Barcelona, 08035 Barcelona, Spain
    World J Hepatol 8:1637-1644. 2016
  9. doi request reprint Safety of bevacizumab in metastatic breast cancer patients undergoing surgery
    Javier Cortes
    Department of Oncology, Vall d Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
    Eur J Cancer 48:475-81. 2012

Detail Information

Publications9

  1. doi request reprint Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma
    Mireia Caralt
    Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Passeig Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Hepatobiliary Pancreat Sci 18:268-75. 2011
    ..The aim of this study was to analyze the outcome of patients undergoing hepatic resection for melanoma liver metastases...
  2. doi request reprint Present and Future of Regenerative Medicine: Liver Transplantation
    M Caralt
    Servei Cirurgia Hepatobiliopancreàtica i Trasplants, Hospital Universitari Vall Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Electronic address
    Transplant Proc 47:2377-9. 2015
    ..However, viability of these transplanted scaffolds is poor owing to the formation of thrombosis. We analyzed the recent advances in decellularizing and recellularizing and the results after transplantation reported in the literature. ..
  3. doi request reprint Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer
    Mireia Caralt
    Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Paseo Vall d Hebron119 129, Barcelona, 08035, Spain
    Ann Surg Oncol 15:2804-10. 2008
    ..Metastatic breast cancer is considered an incurable disease despite new therapies. Recent studies suggest that liver resection associated with systemic treatment may improve patient survival...
  4. doi request reprint Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis
    Gonzalo Sapisochin
    Department of HBP Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Surg Oncol 20:1194-202. 2013
    ..We aimed to assess the long-term outcome of cirrhotic patients with single HCC ≤5 cm treated either with LR or LT on an intention-to-treat basis...
  5. pmc Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre
    Gonzalo Sapisochin
    Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Hepatol Int 5:707-15. 2011
    ..The long-term outcome of patients developing de novo neoplasm (DN) at our centre was evaluated...
  6. doi request reprint Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series
    Gonzalo Sapisochin
    HBP Surgery and Transplantation Department, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Passeig de la Vall d Hebron 119 129, 08035 Barcelona, Spain
    World J Surg 34:2146-54. 2010
    ..The aim of this study was to ascertain the outcome of liver transplantation (LT) due to hepatocellular carcinoma (HCC) in patients who had undergone previous liver resection (LR) for HCC...
  7. ncbi request reprint Does Matching Donor-Recipient Age Affect Long-Term Survival in Liver Transplantation?
    Cristina Dopazo
    Department of HPB Surgery and Transplants, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Transplant 21:708-716. 2016
    ..40, p 0.074) and <60 years (HR 1.47, p 0.070). CONCLUSIONS Older donor age did not negatively affect survival regardless of recipient age, and comparable outcomes were achieved without an increased rate of complications...
  8. pmc Isolated bilateral Tapia's syndrome after liver transplantation: A case report and review of the literature
    Itxarone Bilbao
    Itxarone Bilbao, Cristina Dopazo, Mireia Caralt, Lluis Castells, Elisabeth Pando, Amaia Gantxegi, Ramón Charco, Department of Digestive Surgery, Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitario Vall d Hebron, CIBERehd, Universidad Autonoma de Barcelona, 08035 Barcelona, Spain
    World J Hepatol 8:1637-1644. 2016
    ..To describe one case of bilateral Tapia's syndrome in a liver transplanted patient and to review the literature...
  9. doi request reprint Safety of bevacizumab in metastatic breast cancer patients undergoing surgery
    Javier Cortes
    Department of Oncology, Vall d Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
    Eur J Cancer 48:475-81. 2012
    ..Evaluate the safety of surgery in relation to bevacizumab in the first-line treatment of metastatic breast cancer (mBC) in two international trials...